Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial

American Journal of Cardiology

Volumn 104, Issue 8, 2009, Pages 1055-1062

  Maron, David J ^a   Spertus, John A ^b   Mancini, G B John ^c   Hartigan, Pamela M ^d   Sedlis, Steven P ^e   Bates, Eric R ^f   Kostuk, William J ^g   Dada, Marcin ^h   Berman, Daniel S ⁱ   Shaw, Leslee J ^j   Chaitman, Bernard R ^k   Teo, Koon K ^l   O'Rourke, Robert A ^m   Weintraub, William S ⁿ   Boden, William E ^o  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d VA Cooperative Studies Program Coordinating Center   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^g LONDON HEALTH SCIENCES CENTRE   (Canada)

^h HARTFORD HOSPITAL   (United States)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

^j EMORY UNIVERSITY   (United States)

^k SAINT LOUIS UNIVERSITY   (United States)

^l MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^m SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

ⁿ CHRISTIANA CARE HEALTH SYSTEM   (United States)

^o BUFFALO GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE; ISOSORBIDE MONONITRATE; LISINOPRIL; LOSARTAN; METOPROLOL; NICOTINIC ACID; SIMVASTATIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QUALITY OF LIFE; STABLE ANGINA PECTORIS;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CANADA; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; NITRATES; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; QUALITY OF LIFE; TIME FACTORS; UNITED STATES;

EID: 70349610314     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.05.056     Document Type: Article

References (22)

1. Boden W.E., O'Rourke R.A., Teo K.K., Hartigan P.M., Maron D.J., Kostuk W.J., Knudtson M., Dada M., Casperson P., Harris C.L., Chaitman B.R., Shaw L., Gosselin G., Nawaz S., Title L.M., Gau G., Blaustein A.S., Booth D.C., Bates E.R., Spertus J.A., Berman D.S., Mancini G.B., and Weintraub W.S. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007) 1503-1516
2. Weintraub W.S., Spertus J.A., Kolm P., Maron D.J., Zhang Z., Jurkovitz C., Zhang W., Hartigan P.M., Lewis C., Veledar E., Bowen J., Dunbar S.B., Deaton C., Kaufman S., O'Rourke R.A., Goeree R., Barnett P.G., Teo K.K., Boden W.E., and Mancini G.B. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 359 (2008) 677-687
3. Boden W.E., O'Rourke R.A., Teo K.K., Hartigan P.M., Maron D.J., Kostuk W., Knudtson M., Dada M., Casperson P., Harris C.L., Spertus J.A., Shaw L., Chaitman B.R., Mancini G.B., Berman D.S., and Weintraub W.S. Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424. Am Heart J 151 (2006) 1173-1179
4. Gibbons R.J., Abrams J., Chatterjee K., Daley J., Deedwania P.C., Douglas J.S., Ferguson Jr. T.B., Fihn S.D., Fraker Jr. T.D., Gardin J.M., O'Rourke R.A., Pasternak R.C., and Williams S.V. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 41 (2003) 159-168
5. Braunwald E., Antman E.M., Beasley J.W., Califf R.M., Cheitlin M.D., Hochman J.S., Jones R.H., Kereiakes D., Kupersmith J., Levin T.N., Pepine C.J., Schaeffer J.W., Smith III E.E., Steward D.E., Theroux P., Gibbons R.J., Alpert J.S., Faxon D.P., Fuster V., Gregoratos G., Hiratzka L.F., Jacobs A.K., and Smith Jr. S.C. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
6. Spertus J.A., Winder J.A., Dewhurst T.A., Deyo R.A., Prodzinski J., McDonell M., and Fihn S.D. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 25 (1995) 333-341
7. Spertus J.A., Winder J.A., Dewhurst T.A., Deyo R.A., and Fihn S.D. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 74 (1994) 1240-1244
8. Spertus J.A., Jones P., McDonell M., Fan V., and Fihn S.D. Health status predicts long-term outcome in outpatients with coronary disease. Circulation 106 (2002) 43-49
9. Zhang Z., Mahoney E.M., Stables R.H., Booth J., Nugara F., Spertus J.A., and Weintraub W.S. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial. Circulation 108 (2003) 1694-1700
10. Theroux P., and Fuster V. Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation 97 (1998) 1195-1206
11. Weaver W.D., Simes R.J., Betriu A., Grines C.L., Zijlstra F., Garcia E., Grinfeld L., Gibbons R.J., Ribeiro E.E., DeWood M.A., and Ribichini F. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 278 (1997) 2093-2098
12. Keeley E.C., Boura J.A., and Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361 (2003) 13-20
13. Ottervanger J.P., Armstrong P., Barnathan E.S., Boersma E., Cooper J.S., Ohman E.M., James S., Wallentin L., and Simoons M.L. Association of revascularisation with low mortality in non-ST elevation acute coronary syndrome: a report from GUSTO IV-ACS. Eur Heart J 25 (2004) 1494-1501
14. Mehta S.R., Cannon C.P., Fox K.A., Wallentin L., Boden W.E., Spacek R., Widimsky P., McCullough P.A., Hunt D., Braunwald E., and Yusuf S. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 293 (2005) 2908-2917
15. Shaw L.J., Berman D.S., Maron D.J., Mancini G.B., Hayes S.W., Hartigan P.M., Weintraub W.S., O'Rourke R.A., Dada M., Spertus J.A., Chaitman B.R., Friedman J., Slomka P., Heller G.V., Germano G., Gosselin G., Berger P., Kostuk W.J., Schwartz R.G., Knudtson M., Veledar E., Bates E.R., McCallister B., Teo K.K., and Boden W.E. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial nuclear substudy. Circulation 117 (2008) 1283-1291
16. Malenka D.J., Kaplan A.V., Lucas F.L., Sharp S.M., and Skinner J.S. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents. JAMA 299 (2008) 2868-2876
17. Tu J.V., Bowen J., Chiu M., Ko D.T., Austin P.C., He Y., Hopkins R., Tarride J.E., Blackhouse G., Lazzam C., Cohen E.A., and Goeree R. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357 (2007) 1393-1402
18. Mauri L., Silbaugh T.S., Wolf R.E., Zelevinsky K., Lovett A., Zhou Z., Resnic F.S., and Normand S.L. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation 118 (2008) 1817-1827
19. Kastrati A., Mehilli J., Pache J., Kaiser C., Valgimigli M., Kelbaek H., Menichelli M., Sabate M., Suttorp M.J., Baumgart D., Seyfarth M., Pfisterer M.E., and Schomig A. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 1030-1039
20. Spaulding C., Daemen J., Boersma E., Cutlip D.E., and Serruys P.W. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356 (2007) 989-997
21. Stettler C., Wandel S., Allemann S., Kastrati A., Morice M.C., Schomig A., Pfisterer M.E., Stone G.W., Leon M.B., de Lezo J.S., Goy J.J., Park S.J., Sabate M., Suttorp M.J., Kelbaek H., Spaulding C., Menichelli M., Vermeersch P., Dirksen M.T., Cervinka P., Petronio A.S., Nordmann A.J., Diem P., Meier B., Zwahlen M., Reichenbach S., Trelle S., Windecker S., and Juni P. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
22. James S.K., Stenestrand U., Lindback J., Carlsson J., Schersten F., Nilsson T., Wallentin L., and Lagerqvist B. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 360 (2009) 1933-1945